HomePortfoliosWorld (55% USA)

World (55% USA)

Surperformer le MSCI world avec une exposition moins forte aux USA

Optimize
None Rebalancing
EUR
Moderate Risk
2.1yr backtest

Performance Summary

Total Return+39.83%
Annualized Return+16.88%
Volatility+13.46%
Sharpe Ratio1.11
Max Drawdown+17.37%

Holdings

Asset Allocation

Asset Class

Equity 100.0%
Holdings Details
World diversified equity portfolio with 55% USA exposure, designed to outperform MSCI World with optimized global market allocation in EUR.
AssetTypeAllocationTER
SPPE.XETRA
State Street SPDR S&P 500 UCITS ETF EUR HedgedIE00BYYW2V44
ETF
55.0%0.05%
EXUS.XETRA
Xtrackers MSCI World ex USA UCITS ETF 1CIE0006WW1TQ4
ETF
27.0%0.15%
EUNM.XETRA
iShares MSCI EM UCITS ETF (Acc)IE00B4L5YC18
ETF
12.0%0.18%
UFMA.XETRA
UBS Core MSCI Japan UCITS ETF hEUR accLU1169822266
ETF
3.0%0.15%
XCS5.XETRA
Xtrackers MSCI India Swap UCITS ETF 1CLU0514695187
ETF
3.0%0.19%
Total100.0%0.10%

Performance

Portfolio Value Over Time
Starting with 10,000 investment → now worth €13,982.87
Histogram of Monthly Returns
The portfolio had a positive return during 19 of the 27 months (70%)
Monthly Returns Heatmap
Best month: +9.5% • Worst month: -7.3% • Best year: 2025 (+16.0%) • Worst year: 2026 (+8.5%)
YearJanFebMarAprMayJunJulAugSepOctNovDecTotal
2026+2.0%+1.9%-7.3%+9.5%+3.0%-------+8.5%
2025+3.5%-2.1%-4.4%-1.4%+5.9%+2.8%+2.6%+0.9%+2.9%+3.6%-0.1%+1.1%+16.0%
2024--+2.2%-2.1%+1.8%+4.0%+0.7%+0.6%+2.1%-1.2%+4.1%-1.5%+11.1%
> +2%
0% to +2%
-2% to 0%
< -2%
Drawdown Analysis
Maximum drawdown: +17.37% • The longest drawdown period lasted for 4 months and was between February 2025 and July 2025. It reached a trough of -17.4%.

Detailed Metrics

Returns
Total Return
+39.83%
Annualized Return
+16.88%
Avg Monthly Return
+1.30%
Risk
Volatility (Annual)
+13.46%
Max Drawdown
+17.37%
Positive Months
70%
Average Drawdown
-2.3%
Risk-Adjusted
Sharpe Ratio
1.11
Risk-free rate: 2.0%
Sortino Ratio
1.05
Downside risk adjusted
Return/Volatility
1.25
Calmar Ratio
0.97
Return/Max Drawdown
Ulcer Index
3.20
Drawdown depth & duration
Martin Ratio
0.05
Return/Ulcer Index
Backtest Configuration
Initial Investment
10,000
Final Value
13,982.87
Backtest Period
2024-03-14 to 2026-05-08
2.1 years
Rebalancing
none
Base Currency
EUR